COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 1259: Articles 12581-12590  | Next

Immune response elicited from heterologous SARS-CoV-2 vaccination: Sinovac (CoronaVac) followed by AstraZeneca (Vaxzevria)
Yorsaeng, R., Vichaiwattana, P., Klinfueng, S., Wongsrisang, L., Sudhinaraset, N., Vongpunsawad, S., Poovorawan, Y.
10.1101/2021.09.01.21262955 — Posted: 2021-09-03
Sars-Cov-2 antibody titer 3 months post-vaccination is affected by age, gender, smoking and vitamin D.
Parthymou, A., Habeos, E. E., Habeos, G. I., Deligakis, A., Livieratos, E., Marangos, M., Chartoumpekis, D. V.
10.1101/2021.09.01.21262913 — Posted: 2021-09-03
Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression
Townsend, L., Dyer, A. H., Naughton, A., Imangaliyev, S., Dunne, J., Kiersey, R., Holden, D., Mooney, A., Leavy, D., Ridge, K., Sugrue, J., Aldoseri, M., Kelliher, J. H., Hennessy, M., Byrne, D. G., Browne, P., Bacon, C. L., Doyle, C., O'Riordan, R., McLaughlin, A. M., Bannan, C., Martin-Loeches, I., White, A., McLoughlin, R. M., Bergin, C., Bourke, N., O'Farrelly, C., Conlon, N., Ni Cheallaigh, C.
10.1101/2021.09.01.21262953 — Posted: 2021-09-03
Wildlife in Cameroon harbor diverse coronaviruses including many isolates closely related to human coronavirus 229E
Ntumvi, N. F., Ngum Ndze, V., Gillis, A., Le Doux Diffo, J., Tamoufe, U., Takuo, J.-M., Mouiche, M. M. M., Nwobegahay, J., LeBreton, M., Rimoin, A. W., Schneider, B. S., Monagin, C., McIver, D. J., Roy, S., Ayukekbong, J. A., Saylors, K., Joly, D. O., Wolfe, N. D., Rubin, E. M., Lange, C. E.
10.1101/2021.09.03.458874 — Posted: 2021-09-03
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs
van der Donk, L. E. H., Eder, J., van Hamme, J. L., Brouwer, P. J. M., Brinkkemper, M., van Nuenen, A. C., van Gils, M. J., Sanders, R. W., Kootstra, N. A., Bermejo-Jambrina, M., Geijtenbeek, T. B. H.
10.1101/2021.09.02.458667 — Posted: 2021-09-03
Characterization of SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta) and B.1.618 on cell entry, host range, and sensitivity to convalescent plasma and ACE2 decoy receptor
Ren, W., Ju, X., Gong, M., Lan, J., Yu, Y., Long, Q., Zhang, Y., Zhong, J., Zhong, G., Wang, X., Huang, A., Zhang, R., Ding, Q.
10.1101/2021.09.03.458829 — Posted: 2021-09-03
Strengthening public COVID-19 response with private facilities in Kisumu, Kenya
van Duijn, S., Barsosio, H. C., Omollo, M., Milimo, E., Odero, I. A., Aroka, R., de Sanctis, T., K Oloo, A., June, M. J., Houben, N., Wilming, C., Otieno, K., Kariuki, S., Onsongo, S., Odhiambo, A., Rinke de Wit, T.
10.1101/2021.08.31.21262891 — Posted: 2021-09-03
The impact of mental health and substance use issues on COVID-19 vaccine readiness: a cross sectional community-based survey in Ontario, Canada
Mehra, K., Markoulakis, R., Kodeeswaran, S., Redelmeier, D., Sinyor, M., MacKillop, J., Cheung, A., Levitt, E. E., Addison, T., Levitt, A. J.
10.1101/2021.08.30.21262844 — Posted: 2021-09-03
The COVID-19 pandemic and ophthalmic care: a qualitative study of patients with neovascular age-related macular degeneration (nAMD)
O'Connor, S. R., Treanor, C., Ward, E., Wickens, R. A., O'Connell, A., Culliford, L. A., Rogers, C. A., Gidman, E. A., Peto, T., Knox, P. C., Burton, B. J. L., Lotery, A. J., Sivaprasad, S., Reeves, B. C., Hogg, R. E., Donnelly, M., The MONARCH Study Group
10.1101/2021.09.01.21262696 — Posted: 2021-09-03
Tracking Covid-19 Cases and Deaths in the United States Distribution of Events by Day of Pandemic
Moore, A., Lyu, M., Hall, R.
10.1101/2021.08.30.21262851 — Posted: 2021-09-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).